Skip to main content
FinSpry Logo
FinSpry
PSTV logo
PSTV
(NASDAQ)
Plus Therapeutics, Inc.
$3.78-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Plus Therapeutics (PSTV) Stock Price & Financial Analysis

Plus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.72 - $3.89
52-Week High$15.33
52-Week Low$0.39
Open$3.77
Volume62.48K
Average Volume (3M)195.84K
Market Cap25.12M
Shares Outstanding6.65M
Price to Sales (P/S)4.85
Price to Book (P/B)2.10
EV/EBITDA-1.50
Revenue (TTM)5.18M
Net Income (TTM)-11.93M
Free Cash Flow (TTM)-21.72M
EPS (TTM)$-3.26
Profit Margin-230.24%
Operating Margin-364.36%
Return on Equity (ROE)-99.75%
Debt to Equity0.06
50-Day MA$4.89
200-Day MA$4.50
52-Week Change671.43%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Plus Therapeutics

What is the current stock price for PSTV?

As of the latest trading session, PSTV stock trades at $3.78. The 52-week range is $0.39–$15.33, with a day range of $3.72–$3.89.

What is the P/E ratio for PSTV?

The P/E ratio (Price-to-Earnings) for PSTV is shown in the Key Statistics section. This valuation metric helps compare Plus Therapeutics, Inc. to industry peers.

Does PSTV pay dividends?

Plus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PSTV?

Based on 3 analysts, the consensus for PSTV is Buy.

What is the market cap of PSTV?

Plus Therapeutics's market capitalization is $25.1M, classifying it as a micro-cap company. Plus Therapeutics operates in the Healthcare sector within the Biotechnology industry.